Philippines Details Grace Periods for Implementation of Amendments to ASEAN Cosmetic Directive

Philippines Food and Drug Administration (FDA) has consulted representatives of the different sectors of the cosmetic industry through a series of regular meetings to get their feedback on a feasible and fair grace period.

ASEAN Cosmetic Directive (ACD) was updated during the 21st ASEAN Cosmetic Committee, 20th and 21st ASEAN Cosmetic Scientific Body and 4th ASEAN Cosmetic Testing Laboratory Committed Meeting. The grace periods allocated to industry to comply with new regulations must take into consideration the processes involved in complying with new regulations such as product reformulation, product development and initiation of product phase-outs. As such the Philippines Food and Drug Administration (FDA) has consulted representatives of the different sectors of the cosmetic industry through a series of regular meetings to get their feedback on a feasible and fair grace period. Adjusted grace periods as presented below are been officially used by Philippines FDA:

Amendments	Agreed Grace Period
Annex II
1374-1378	Existing products can be in the market until December 31st 2015
Annex III
1a	Immediate effect
286	Until July 1st 2015 or earlier for products to be placed in the market and December 1st 2015 for existing products in the market.
287
Annex IV
CI 77510	Immediate effect
Annex VI
12 and 12a	Local grace period/timeline will be moved to “until end of to March 2016, and for existing products in the market will be end of September 2016”
25	End of December 2015 but subject to review at the next ACSB meeting
39	Local grace period/timeline will be moved to “until Oct 1st 2015 or earlier, for products to be placed in the market and July 2016 for existing products in the market”
57
59	Immediate effect
Annex VII
29	Immediate effect

*Please click here to see the detailed amendments of the ASEAN Cosmetic Directive.